Date November 1, 2017
Map Boston, Massachusetts

The latest scientific information presented at this year’s Clinical Trials for Alzheimer’s Disease meeting make clear that the development of new treatments for AD will depend upon innovative strategies for assessing cognition and functioning in these patients. Two of the latest tools from NeuroCog Trials were described during the scientific sessions: